Smith & Nephew PLC logo

Smith & Nephew PLC

R$ 27.75 (0%) Dec 5
P/E:
24.87
P/B:
2.17
Market Cap:
R$ 24.16B ($ 4.58B)
Enterprise V:
R$ 73.31B ($ 13.88B)
Volume:
-
Avg Vol (2M):
735.00
Also Trade In:
Volume:
-
Market Cap R$:
24.16B
Market Cap $:
4.58B
PE Ratio:
24.87
Avg Vol (2-Month):
735.00
Enterprise Value R$:
73.31B
Enterprise Value $:
13.88B
PB Ratio:
2.17
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Financials (Next Earnings Date:2023-02-21)

BSP:S1NN34's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 27,900.274
EPS (TTM) (R$) 3.078
Beta 0
Volatility % 31.16
14-Day RSI 81.86
14-Day ATR (R$) 0.140907
20-Day SMA (R$) 26.714
12-1 Month Momentum % -34.13
52-Week Range (R$) 23.52 - 38.85
Shares Outstanding (Mil) 870.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Smith & Nephew PLC Filings

Document Form Filing Date
No Filing Data

Smith & Nephew PLC Analysis

Share your research